Allergan, now part of AbbVie, discovers and develops innovative medicines and products across therapeutic areas including oncology, immunology, aesthetics, and eye care.
Subscribe to see Allergan’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of Allergan's closest competitors — see the full list of competitors and alternatives →
Johnson & Johnson develops and delivers advanced medicines and medical technologies to address complex global health challenges. The company provides innovative treatments and devices across therapeutic areas including oncology, immunology, neuroscience, cardiovascular care, orthopaedics, surgery, and vision for patients worldwide.
Galderma Group is a dermatology company that develops and provides products across three main segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. It serves patients, consumers, and healthcare professionals globally.
Esprit Pharma, Inc. is a privately held, niche-oriented pharmaceutical company founded in 2004 and headquartered in East Brunswick, New Jersey, specializing in producing pharmaceutical products before being acquired by Allergan.
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers transformational medicines for patients with serious diseases. The company focuses on therapeutic areas including oncology, hematology, neuroscience, immunology, and cardiovascular research.
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.